Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review

The new drugs delamanid and bedaquiline are increasingly being used to treat multidrug-resistant (MDR-) and extensively drug-resistant tuberculosis (XDR-TB). The World Health Organization, based on lack of evidence, recommends their use under specific conditions and not in combination. No systematic...

Descripción completa

Detalles Bibliográficos
Autores principales: Migliori, Giovanni Battista, Pontali, Emanuele, Sotgiu, Giovanni, Centis, Rosella, D’Ambrosio, Lia, Tiberi, Simon, Tadolini, Marina, Esposito, Susanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343876/
https://www.ncbi.nlm.nih.gov/pubmed/28178199
http://dx.doi.org/10.3390/ijms18020341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343876/
https://www.ncbi.nlm.nih.gov/pubmed/28178199
http://dx.doi.org/10.3390/ijms18020341

Ejemplares similares